M&T Bank Corp Halozyme Therapeutics, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 111,239 shares of HALO stock, worth $5.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

111,239

Previous 111,239 -0.0%

Holding current value

$5.46 Million

Previous $6.36 Million -0.0%

% of portfolio

0.02%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$51.3 - $64.42 $28,779 - $36,139	561 Added 0.51%	111,239 $6.36 Million
Q2 2024 Jul 31, 2024	BUY	$37.81 - $52.4 $316,167 - $438,168	8,362 Added 8.17%	110,678 $5.8 Million
Q1 2024 May 07, 2024	BUY	$33.68 - $41.95 $201,877 - $251,448	5,994 Added 6.22%	102,316 $4.16 Million
Q4 2023 Feb 06, 2024	BUY	$33.32 - $42.1 $28,721 - $36,290	862 Added 0.9%	96,322 $3.56 Million
Q3 2023 Nov 02, 2023	SELL	$36.46 - $44.03 $21,730 - $26,241	-596 Reduced 0.62%	95,460 $3.65 Million
Q2 2023 Aug 09, 2023	BUY	$30.28 - $38.74 $4,420 - $5,656	146 Added 0.15%	96,056 $3.46 Million
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $165,811 - $281,062	5,046 Added 5.55%	95,910 $3.66 Million
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $1.75 Million - $2.6 Million	43,714 Added 92.71%	90,864 $5.17 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $2.17 Million - $3.22 Million	-54,127 Reduced 53.44%	47,150 $2.68 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $40,417 - $54,317	-1,049 Reduced 1.03%	101,277 $4.01 Million
Q2 2022 Aug 05, 2022	BUY	$37.35 - $48.3 $1.91 Million - $2.47 Million	51,163 Added 100.0%	102,326 $4.5 Million
Q4 2021 Feb 07, 2022	BUY	$31.82 - $40.75 $169,027 - $216,464	5,312 Added 11.59%	51,163 $2.06 Million
Q3 2021 Oct 28, 2021	SELL	$38.47 - $46.42 $6,424 - $7,752	-167 Reduced 0.36%	45,851 $1.87 Million
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $77,680 - $102,620	-2,000 Reduced 4.17%	46,018 $2.09 Million
Q1 2021 May 06, 2021	SELL	$39.51 - $51.45 $215,210 - $280,248	-5,447 Reduced 10.19%	48,018 $2 Million
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $121,332 - $205,057	-4,701 Reduced 8.08%	53,465 $2.28 Million
Q3 2020 Nov 06, 2020	BUY	$25.74 - $29.63 $202,934 - $233,602	7,884 Added 15.68%	58,166 $1.53 Million
Q2 2020 Jul 29, 2020	SELL	$16.25 - $26.81 $46,572 - $76,837	-2,866 Reduced 5.39%	50,282 $1.35 Million
Q1 2020 May 14, 2020	BUY	$13.9 - $21.83 $71,307 - $111,987	5,130 Added 10.68%	53,148 $956,000
Q4 2019 Feb 07, 2020	BUY	$14.93 - $19.53 $63,855 - $83,529	4,277 Added 9.78%	48,018 $852,000
Q3 2019 Nov 12, 2019	BUY	$15.2 - $17.69 $1,489 - $1,733	98 Added 0.22%	43,741 $679,000
Q2 2019 Aug 12, 2019	SELL	$14.75 - $17.26 $14,750 - $17,260	-1,000 Reduced 2.24%	43,643 $750,000
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $55,760 - $70,320	-4,000 Reduced 8.22%	44,643 $719,000
Q4 2018 Feb 01, 2019	BUY	$13.33 - $18.66 $190,365 - $266,483	14,281 Added 41.56%	48,643 $711,000
Q2 2017 Aug 11, 2017	BUY	N/A	34,362	34,362 $441,000

Others Institutions Holding HALO

# of Institutions

544

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account